Literature DB >> 16552036

Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera.

Anisia J Silva1, Gordon J Leitch, Andrew Camilli, Jorge A Benitez.   

Abstract

Vibrio cholerae is a highly motile organism that secretes a Zn-dependent metalloprotease, hemagglutinin/protease (HapA). HapA has been shown to have mucinase activity and contribute to the reactogenicity of live vaccine candidates, but its role in cholera pathogenesis is not yet clear. The contribution of motility to pathogenesis is not fully understood, since conflicting results have been obtained with different strains, mutants, and animal models. The objective of this work was to determine the contribution of HapA and motility to the pathogenesis of El Tor biotype cholera. To this end we constructed isogenic motility (motY) and mucinase (hapA) single and double mutants of an El Tor biotype V. cholerae strain. Mutants were characterized for the expression of major virulence factors in vitro and in vivo. The motility mutant showed a remarkable increase in cholera toxin (CT), toxin coregulated pilus major subunit (TcpA), and HapA production in vitro. Increased TcpA and CT production could be explained by increased transcription of tcpA, ctxA, and toxT. No effect was detected on the transcription of hapA in the motility mutant. The sodium ionophore monensin diminished production of HapA in the parent but not in the motility mutant. Phenamil, a specific inhibitor of the flagellar motor, diminished CT production in the wild-type and motY strains. The hapA mutant showed increased binding to mucin. In contrast, the motY mutation diminished adherence to biotic and abiotic surfaces including mucin. Lack of HapA did not affect colonization in the suckling mouse model. The motility and mucinase defects did not prevent induction of ctxA and tcpA in the mouse intestine as measured by recombinase-based in vivo expression technology. Analysis of mutants in the rabbit ileal loop model showed that both V. cholerae motility and HapA were necessary for full expression of enterotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552036      PMCID: PMC1418906          DOI: 10.1128/IAI.74.4.2072-2079.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Vibrio cholerae hemagglutinin/protease (HA/protease) causes morphological changes in cultured epithelial cells and perturbs their paracellular barrier function.

Authors:  Z Wu; D Milton; P Nybom; A Sjö; K E Magnusson
Journal:  Microb Pathog       Date:  1996-08       Impact factor: 3.738

3.  Bile affects production of virulence factors and motility of Vibrio cholerae.

Authors:  S Gupta; R Chowdhury
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.

Authors:  A Robert; A Silva; J A Benitez; B L Rodriguez; R Fando; J Campos; D K Sengupta; M Boesman-Finkelstein; R A Finkelstein
Journal:  Vaccine       Date:  1996-11       Impact factor: 3.641

5.  A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.

Authors:  V L Miller; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

6.  The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.

Authors:  Luis García; Manuel Díaz Jidy; Hilda García; Boris L Rodríguez; Roberto Fernández; Gemma Año; Bárbara Cedré; Tania Valmaseda; Edith Suzarte; Margarita Ramírez; Yadira Pino; Javier Campos; Jorge Menéndez; Rodrigo Valera; Daniel González; Irma González; Oliver Pérez; Teresita Serrano; Miriam Lastre; Fernando Miralles; Judith Del Campo; Jorge Luis Maestre; José Luis Pérez; Arturo Talavera; Antonio Pérez; Karen Marrero; Talena Ledón; Rafael Fando
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression.

Authors:  C L Gardel; J J Mekalanos
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

8.  Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.

Authors:  K Richardson
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment.

Authors:  R A Finkelstein; M Boesman-Finkelstein; Y Chang; C C Häse
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  The effect on enterotoxicity of protease purified from Vibrio cholerae O1.

Authors:  Y Ichinose; M Ehara; T Honda; T Miwatani
Journal:  FEMS Microbiol Lett       Date:  1994-01-15       Impact factor: 2.742

View more
  41 in total

Review 1.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

Review 2.  Regulatory networks controlling Vibrio cholerae virulence gene expression.

Authors:  Jyl S Matson; Jeffrey H Withey; Victor J DiRita
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

3.  Attenuation of bacterial virulence by quorum sensing-regulated lysis.

Authors:  Anisia J Silva; Jorge A Benitez; Jian-He Wu
Journal:  J Biotechnol       Date:  2010-07-29       Impact factor: 3.307

4.  A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae.

Authors:  Lynn Rasmussen; E Lucile White; Ashish Pathak; Julio C Ayala; Hongxia Wang; Jian-He Wu; Jorge A Benitez; Anisia J Silva
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

5.  Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.

Authors:  Zhu Wang; David W Lazinski; Andrew Camilli
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

6.  Lipidation of an FlrC-dependent protein is required for enhanced intestinal colonization by Vibrio cholerae.

Authors:  David C Morris; Fen Peng; Jeffrey R Barker; Karl E Klose
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

7.  A novel dnaJ family gene, sflA, encodes an inhibitor of flagellation in marine Vibrio species.

Authors:  Maya Kitaoka; Takehiko Nishigaki; Kunio Ihara; Noriko Nishioka; Seiji Kojima; Michio Homma
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

Review 8.  Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities.

Authors:  Jorge A Benitez; Anisia J Silva
Journal:  Toxicon       Date:  2016-03-04       Impact factor: 3.033

9.  The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors.

Authors:  Khalid Ali Syed; Sinem Beyhan; Nidia Correa; Jessica Queen; Jirong Liu; Fen Peng; Karla J F Satchell; Fitnat Yildiz; Karl E Klose
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

Review 10.  Exploiting cholera vaccines as a versatile antigen delivery platform.

Authors:  Anisia J Silva; Francis O Eko; Jorge A Benitez
Journal:  Biotechnol Lett       Date:  2007-11-16       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.